bevacizumab,atezolizumab
roche
['atezo', 'imbrave050', 'hcc']
 efficacy, safety &amp; pros from imbrave050: adj. atezobev vs active surveillance in #hcc #asco23 phs-iii irf-rfs hr: 0.72 gr. 3/4 aes in 41% of pts with atezobev no clinically meaningful deteriorationof hrqol os benefit? #livertwitter 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology